lecanemab and what this means for the future treatment of alzheimer’s disease
Published 1 year ago • 363 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
2:02
lecanemab for the treatment of early alzheimer’s disease: the story so far
-
6:55
lecanemab - a breakthrough in treating alzheimer´s disease?
-
17:28
lecanemab: a potential new drug for alzheimer's disease
-
2:11
fda approval of lecanemab: what does the data tell us about the amyloid hypothesis?
-
1:25:31
lecanemab for treatment of early alzheimer’s disease: overview & clinician perspectives
-
3:02
lecanemab: drawbacks to consider
-
3:01
potential breakthrough: new treatment for alzheimer's
-
5:24
lecanemab: a review
-
4:32
how soon could lecanemab be prescribed to treat alzheimer's?
-
15:12
lecanemab and the new potential of anti-abeta therapies for alzheimer's
-
1:23
updates in pharmacological treatment of alzheimer’s disease: lecanemab, donanemab and gantenerumab
-
5:49
how new alzheimer's drug leqembi works, risks and who might benefit
-
1:57
phase iii ahead 3-45 trial of lecanemab for preclinical alzheimer’s disease
-
27:37
is a disease-slowing treatment for alzheimer’s disease on the horizon?
-
18:43
mayo clinic q&a podcast: mayo clinic experts discuss new alzheimer’s treatment option
-
1:31
breakthrough in alzheimer's disease treatment
-
1:38
the potential of lecanemab for the treatment of early alzheimer’s disease
-
5:01
what the new alzheimer's disease drug means for patients
-
59:20
what's lecanemab and what's next?